The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
News & media
News and media releases about the regulation of controlled drugs in Australia, as well as committee meetings, webinars and consultations.
Loading...
News and media menu
Published date
- March 2025 (1)
- December 2024 (2)
- November 2024 (1)
- September 2024 (1)
- August 2024 (1)
- July 2024 (1)
- May 2024 (1)
- March 2024 (1)
- February 2024 (1)
- January 2024 (1)
- December 2023 (3)
- November 2023 (2)
- September 2023 (2)
- August 2023 (2)
- July 2023 (1)
- June 2023 (1)
- March 2023 (2)
- December 2022 (3)
- November 2022 (1)
- July 2022 (1)
- December 2021 (1)
- August 2021 (1)
- July 2021 (1)
- June 2021 (1)
- April 2021 (1)
- February 2021 (1)
- December 2020 (1)
- November 2020 (2)
- October 2020 (2)
- September 2020 (1)
- July 2020 (1)
- June 2020 (1)
- May 2020 (1)
- January 2020 (3)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- June 2019 (2)
- April 2019 (1)
- March 2019 (1)
- December 2018 (2)
- October 2018 (1)
- July 2018 (1)
- May 2018 (1)
- March 2018 (1)
- January 2018 (2)
- October 2017 (1)
- August 2017 (2)
- June 2017 (5)
- May 2017 (2)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- December 2016 (1)
- October 2016 (2)
- September 2016 (1)
- August 2016 (1)
- July 2016 (1)
Search
81 result(s) found, displaying 1 to 25
- New substances controlled under the Customs (Prohibited Imports) Regulations 1956 and Customs (Prohibited Exports) Regulations 1958From 1 March 2025, new substances included under Schedule 4 of the Customs (Prohibited Imports) Regulations 1956 will require a licence and permit for import and/or export issued by us.
- MCEWG, Meeting 3, 16 October 2024The Medicinal Cannabis Expert Working Group (MCEWG) met for its third meeting in Melbourne on Wednesday 16 October 2024.
- More Portal functionalities coming in 2025We will be progressively adding more digital forms and enhanced functionality, enabling you to complete a range of tasks online.
- Health Business Services (HBS) Portal now availableThe HBS Portal is open for new medicinal cannabis and narcotic drug manufacture licence applications to the Office of Drug Control.
- MCEWG, Meeting 2, 17 July 2024The Medicinal Cannabis Expert Working Group (MCEWG) met for its second meeting in Canberra on Wednesday 17 July 2024
- Updated Australian cannabis dataThe 2023 data on cannabis-related activities regulated by the Office of Drug Control is now available.
- MCEWG, Meeting 1, 17 April 2024The Medicinal Cannabis Expert Working Group (MCEWG) met for its first meeting in Melbourne on Wednesday 17 April 2024
- Update on new online forms for licence applicationsWe are transitioning to an online system for submitting new licence applications from mid-2024. The changes will affect how you will submit a new licence application.
- ODC transformation programThis year we will be establishing an online portal, making it easier and more convenient for you to do business with us.
- New substances controlled under the Customs (Prohibited Imports) Regulations 1956 and Customs (Prohibited Exports) Regulations 1958Find out about new substances requiring a licence and permit for import and/or export issued by us, the Office of Drug Control (ODC), From 21 February 2024.
- New import controls on vaping goods from 1 January 2024New import controls have been introduced for vaping goods under the Customs (Prohibited Imports) Regulations 1956.
- The Kava Pilot and the final reportThe Kava pilot ends on 31 December 2023. The Australian Government will make a decision on future imports of kava. Until then, importers can continue to apply for import permission for kava. Read the final report.
- New substances controlled under the Customs (Prohibited Imports) Regulations 1956 and Customs (Prohibited Exports) Regulations 1958From 13 December 2023 there are new substances requiring a licence and permit for import and export.
- New Australian cannabis data webpageFind out information about the quantity of cannabis imported, exported, produced, and held in stock.
- New regulations to place stronger controls on importation, manufacture and supply of vapesThe changes will help address the significant public health issues caused by vaping in Australia, while keeping legitimate patient access to therapeutic vapes.
- Cannatrek Technologies Pty Ltd fined $99,000 for alleged breaches of the Narcotic Drugs ActWe have issued six infringement notices totalling $99,000 to Queensland-based company Cannatrek Technologies Pty Ltd (Cannatrek) for alleged breaches of its medicinal cannabis licence.
- AACMC meeting 21, 10 March 2023The Australian Advisory Council on the Medicinal Use of Cannabis, Communiqué #21.
- AACMC meeting 22, 21 June 2023The Australian Advisory Council on the Medicinal Use of Cannabis, Communiqué #22.
- New licence and permit variation forms for the Medicinal Cannabis Scheme coming soonWe are updating the licence and permit variation forms for the Medicinal Cannabis Scheme.
- Updated information on the regulation of MDMA and psilocybineRead the latest information on the regulation of MDMA and psilocybine.
- New fees and charges for the Medicinal Cannabis SchemeFind out about the new fees and charges for the Medicinal Cannabis Scheme starting in August 2023.
- Media release: Medicinal cannabis licence holder fined for alleged inadequate securityThe ODC has issued an infringement notice to the New South Wales-based company ABC CAN Pty Ltd for alleged security failures at its cannabis cultivation site.
- Compliance and Enforcement Framework releasedRead about our approach to the regulated narcotic industry, and legal obligations for people with ODC licences.
- AACMC meeting 20, 9 December 2022The Australian Advisory Council on the Medicinal Use of Cannabis, Communiqué #20.
- Medicinal Cannabis Program Regulatory Fees and Charges ReviewThis public consultation is open for comment until 10 February 2023.